Dr. James S Brown, M.D. Psychiatry & Neurology - Geriatric Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 214 Bush River Drive, Farmville, VA 23901 Phone: 434-392-3187 Fax: 434-392-5789 |
Dr. Maria Luisa Ganan Almond, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 800 Oak St, Farmville, VA 23901 Phone: 434-200-5999 |
Dr. Norman Brooks Holden Jr., M.D Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 214 Bush River Dr, Farmville, VA 23901 Phone: 434-392-3187 Fax: 434-392-5789 |
Dr. John Dimock, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 214 Bush River Dr, Farmville, VA 23901 Phone: 434-392-3187 Fax: 434-392-5789 |
Shi Yun Lim, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 800 Oak St, Department Of Neurology, Farmville, VA 23901 Phone: 434-315-2928 |
Dr. Steven Bernard Eisenstein, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 161 Bush River Dr, Farmville, VA 23901 Phone: 434-392-6455 Fax: 434-392-5789 |
News Archive
A study published in the 2006 March issue of Psychotherapy and Psychosomatics by a group of Austrian investigators introduces a new simple method for detecting anger attacks.
Rice University researchers have found a potential clue to the roots of epilepsy, autism, schizophrenia and other neurological disorders.
Researchers from The University of Texas Medical Branch at Galveston have discovered a new potential medication that works with an HIV-infected person's own body to further suppress the ever present but silent virus that available HIV treatments are unable to combat.
Americans with lung disease may face a far greater level of lung damage than either they or their doctor suspect, depending on their individual genetic heritage, according to research published online July 7 in the New England Journal of Medicine. The research implications range from diagnosing the severity of asthma, to disability decisions or eligibility for lung transplants, researchers say.
Pieris AG announced today the signature of a collaboration and license agreement with both Sanofi-Aventis and Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, under which Pieris will apply its proprietary Anticalin technology to discover novel Anticalin drugs against multiple targets, with further development undertaken by Sanofi-Aventis and Sanofi-Pasteur. The collaboration will initially involve two targets nominated by Sanofi-Aventis and Sanofi-Pasteur, and includes the option for four additional targets.
› Verified 8 days ago